Taylor Ben R's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Mar 18, 2026
- Accession no.
- 0001712276-26-000002
- Filed
- Mar 18, 2026
- Trade date
- Mar 16-17, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $27.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Taylor Ben RCIK 0001712276 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Class A Common Stock | FTax withholdingDisposed | −7,075 | $3.42 | −$24,196.5 | 1,188,274 | Direct | |
| Mar 17, 2026 | Class A Common Stock | SSaleDisposed | −7,956 | $3.39 | −$26,970.84 | 1,180,318 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.